HIV/HBV Coinfection
HIV/HBV Coinfected Patients Respond to ART as well as HIV Monoinfected
- Details
- Category: HIV/HBV Coinfection
- Published on Friday, 04 September 2009 17:00
- Written by Liz Highleyman
HIV positive people coinfected with hepatitis B virus (HBV) respond as well to combination antiretroviral therapy (ART) as individuals with HIV alone, but they are more likely to die due to non-AIDS-related causes, according to a study published in the September 10, 2009 issue of AIDS.
HIV-HBV Coinfected Patients Respond to Antiretroviral Therapy as well as HIV Monoinfected, but Have a Higher Risk of Non-AIDS Death
- Details
- Category: HIV Treatment
- Published on Friday, 04 September 2009 12:42
- Written by HIVandHepatitis.com
HIV positive people coinfected with hepatitis B virus (HBV) respond as well to combination antiretroviral therapy (ART) as individuals with HIV alone, but they are more likely to die due to non-AIDS-related causes, according to a study published in the September 10, 2009 issue of AIDS.
CROI 2009: Antiretroviral Treatment Interruption May Affect HCV Viral Load, HBV Rebound, and Liver Fibrosis Progression in Coinfected Patients
- Details
- Category: HIV/HBV Coinfection
- Published on Friday, 27 February 2009 12:57
- Written by Liz Highleyman
Over the past few years, evidence has accumulated showing that antiretroviral treatment interruption is a potentially risky strategy, and that ongoing HIV replication is associated with a variety of non-AIDS conditions even in people with relatively well-preserved immune function.
Meta-analysis Shows Concurrent Hepatitis B Increases All-cause Mortality in People with HIV
- Details
- Category: HIV/HBV Coinfection
- Published on Friday, 17 July 2009 13:42
- Written by Liz Highleyman
HIV positive people coinfected with hepatitis B virus (HBV) have a higher rate of all-cause death than people with HIV alone, according to a report in the June 15, 2009 issue of Clinical Infectious Diseases. These results, the study authors stated, suggest that HIV-HBV coinfected individuals may especially benefit from efforts to minimize liver damage.
Liver Enzyme Elevation after Lamivudine (Epivir) Withdrawal in HIV-HBV Coinfected Patients
- Details
- Category: HIV/HBV Coinfection
- Published on Tuesday, 27 January 2009 12:42
- Written by Liz Highleyman
Assessment of liver enzyme elevation in HIV positive patients coinfected with hepatitis B virus (HBV) can be complicated, since increases may be attributable to multiple causes including heavy alcohol use, liver toxicity related to antiretroviral therapy (ART), immune reconstitution due to effective anti-HIV therapy, and exacerbation of HBV infection -- especially when anti-HBV therapy is discontinued.
More Articles...
- Advanced Liver Disease in People with HIV
- Boosted Atazanavir (Reyataz) and Etravirine (Intelence) Are Safe and Well-tolerated in Patients with Hepatitis B or C Coinfection
- ICAAC 2008: Efficacy of Tenofovir (Viread) plus Emtricitabine (Emtriva) in HIV-HBV Coinfected Patients
- Antiviral Therapy May Promote Hepatitis B Virus Genotype Changes
Web Design and Development by